Metraipolis › archive › dc_8ea26a5601ab
Factors supporting optimisation of psychotropic deprescribing in people with intellectual disabilities within the UK: a modified Delphi study — Europe PMC PMID:40904565
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/40904565
- DOI
- 10.3389/fpsyt.2025.1652988
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-10T12:30:46.181Z
- SHA-256 of the archived text
3ae3abaa7613677cb0c84dcd8f91616096468f4b6f497744486c7bf73b04cf03- Stable URL of this page
https://metraipolis.com/documento/dc_8ea26a5601ab
How to cite
Factors supporting optimisation of psychotropic deprescribing in people with intellectual disabilities within the UK: a modified Delphi study — Europe PMC PMID:40904565 — Europe PMC (en), https://europepmc.org/article/MED/40904565 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_8ea26a5601ab (Metraipolis archive dc_8ea26a5601ab, sha256 3ae3abaa7613677cb0c84dcd8f91616096468f4b6f497744486c7bf73b04cf03)
BibTeX
@misc{dc8ea26a5601ab,
title = {Factors supporting optimisation of psychotropic deprescribing in people with intellectual disabilities within the UK: a modified Delphi study — Europe PMC PMID:40904565},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/40904565},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_8ea26a5601ab; sha256 3ae3abaa7613677cb0c84dcd8f91616096468f4b6f497744486c7bf73b04cf03},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40904565. Agents can read the archived copy with the MCP tool read_document.